Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
The Medicines Co.
Pharmaceutical Preparations NJ, United States
Nasdaq: MDCO
Company Description
The Medicines Co. is a pharmaceutical company, which focuses on advancing the treatment of critical care patients through the delivery of medicines to the worldwide hospital marketplace. The company has three marketed products, Angiomax, Cleviprex inject able emulsion and its ready-to-use formulation of Argatroban. Its also have a pipeline of acute and intensive care hospital products in development, including four late-stage development product candidates, cangrelor, oritavancin, MDCO-157 and IONSYS and three early stage development product candidates, MDCO-216, ALN-PCS02 and ALN-PCSsc. Medicines was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.
Similar to: AstraZeneca Plc, GW Pharmaceuticals Plc, BioGaia AB
Featured Company
Zhaikmunai LP
Uralsk, KZ
Zhaikmunai LP is an independent oil and gas company. The company, through its wholly-owned subsidiary, Zhaikmunai LLP, is engaged… Learn more →
Social Monitor
You may also be interested in:
BioGaia AB
Stockholm, SE
BioGaia develops, markets and sells probiotic products with documented health benefits. Its products are primarily based on different… Learn more →
GW Pharmaceuticals Plc
Salisbury, WI, GB
GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →
AstraZeneca Plc
London, LO, GB
AstraZeneca Plc is a global research-based biopharmaceutical company, which discovers, develops and markets medicines for gastrointestinal,… Learn more →